Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. - Wikidata - awgldk - TriplyDB

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

http://www.wikidata.org/entity/Q33378937

about

Post-surgical chemotherapy versus surgery alone for resectable gastric cancer Post-surgical chemotherapy versus surgery alone for resectable gastric cancer Current adjuvant treatment modalities for gastric cancer: From history to the future Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors.Adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis.Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma.Capecitabine with radiation is an effective adjuvant therapy in gastric cancers.Postoperative chemoradiation for resected gastric cancer--is the Macdonald Regimen Tolerable? a retrospective multi-institutional study Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201).A retrospective study on intensity-modulated radiation therapy combined with chemotherapy after D2 radical surgery for gastric carcinoma The Efficacy of Adjuvant FOLFOX6 for Patients With Gastric Cancer after D2 Lymphadenectomy: A Propensity Score-matched Analysis Accomplishments in 2008 in the management of localized gastric cancer Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer Perioperative chemotherapy for gastroesophageal cancer in British Columbia: a multicentre experience.Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.Long-term survival after gastrectomy for cancer in randomized, controlled oncological trials: comparison between West and East.Adjuvant therapy in gastric cancer: what is the optimal approach?Perioperative chemotherapy in locally advanced gastric cancer.Postoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis.What make differences in the outcome of adjuvant treatments for resected gastric cancer?Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.Luteolin induces apoptosis in vitro through suppressing the MAPK and PI3K signaling pathways in gastric cancer.Gastric cancer surveillance in a high-risk population in tuscany (Central Italy): preliminary results.Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975.Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial.Combined perioperative EOX chemotherapy and postoperative chemoradiotherapy for locally advanced gastric cancer.Localized gastric cancer: chemoradiation is not always needed.High FAK combined with low JWA expression: clinical prognostic and predictive role for adjuvant fluorouracil-leucovorin-oxaliplatin treatment in resectable gastric cancer patients.Validity of studies suggesting postsurgical chemotherapy for resectable gastric cancer: critical appraisal of randomised trials.Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma?Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods.Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.Predictors of overall survival after surgery in gastric cancer patients from a Latin-American country.The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study.The effect of adjuvant chemotherapy on stage IV (T4N1-3M0 and T1-3N3M0) gastric cancer.Survival Benefit of Three Different Therapies in Postoperative Patients With Advanced Gastric Cancer: A Network Meta-Analysis

P2860

Q24198252-9D47036A-0C63-4FCE-A767-17ED8C8A419B Q24239943-87536AFE-F9C5-46BF-8560-73B98D27B3B2 Q26748744-87BEDD48-C1EE-4FFA-929E-F9732D9D3676 Q26859950-00465E2B-C9F4-4769-832B-050771F66F11 Q26860637-093B87DA-34B6-4ADD-A5F6-ED918E3A08D4 Q33403424-EE1B4101-5E4F-47D9-ABCE-69D279AB8A69 Q33414608-22BF7A6A-E93B-4FE6-BF07-DF678FB12EA3 Q33427517-1B52A8BB-F307-44BF-A2A7-3E6F5A9ED48A Q34041435-674CC0A3-7F69-4C60-BA24-481F3F9A1547 Q35560032-8CCF21E3-012C-4249-AE48-07A87F809674 Q36747373-F7EAAC13-EA65-4188-A8FD-FBBA1E1519E4 Q36824877-9A91D091-0B50-4AC2-AA19-F96EEA1F3E15 Q36837966-E8409B82-8FFD-4C1D-89CF-2B4B5EA3DAC8 Q37468843-A72E6F65-C183-41C9-BB13-83A58B4C162B Q37609431-B9022768-E83A-4078-BD26-FD68CADAC0A7 Q37719600-FD824D2D-A069-4022-9BA6-45CA546EB428 Q37724644-98169C37-62E9-474F-AFB7-C99E0805350D Q37998931-6858C259-B44F-4A23-AE69-7C68FCC671D8 Q38076028-669A0938-8D3D-4C43-B53C-66CDB9175C17 Q38077141-DFA049F2-3E4B-4F61-BD3C-E32D1CBD437F Q38169894-07895CBF-0A07-42CB-963F-BB8876F0957C Q38226324-D01C0242-5292-45AE-A239-D984D5CBE20A Q38247980-61A4571E-2ADF-4AE0-B832-AB2B16182E82 Q38432288-6FC724E4-3B70-4418-A239-F7258BC0BAA7 Q38695467-84BBBBC5-24F9-427B-ACE3-E7FC328BA077 Q39760422-EBA70D42-4E4E-45CD-8393-7ABAE24204B9 Q39924415-F2E131A3-A3FB-4D4D-9998-ED53D83EC119 Q40162858-7BD473D2-F1A0-481C-9B1E-F98AA2720496 Q41162089-6896D183-59CF-47F8-AEBD-0B1606F6DA78 Q43124347-7F5644E8-10E7-4923-A7CD-8F3234F684E2 Q43640344-494CC9E6-401E-4776-B205-960E42155730 Q45197627-2BF1B247-4883-464A-B4AC-AB3073070AF6 Q46737731-E0212423-08BD-4861-ABAE-FA0C490B2DCF Q46887397-238E8AB0-782F-4E53-88F0-E014D0503B8E Q48626617-E8FF84B2-5A83-456B-A15B-076584503B90 Q53320199-C1519407-98C9-4F63-8F4C-6BE4184E50F4 Q54941136-A9B7A05C-70A9-48F7-A7FE-C6FB898570DE Q55007776-A1C08552-1519-4B58-9FC1-9A3B136F7E2D Q55071100-478779DB-0C40-4CFD-8187-DCBCC3590608 Q58718986-B17EAF72-B6A6-45D7-A4A4-EB4C3571BCDE

P2860

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

http://www.wikidata.org/entity/Q33378937

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Adjuvant chemotherapy in compl ...... III trial conducted by GOIRC.

@ast

Adjuvant chemotherapy in compl ...... III trial conducted by GOIRC.

@en

type

label

Adjuvant chemotherapy in compl ...... III trial conducted by GOIRC.

@ast

Adjuvant chemotherapy in compl ...... III trial conducted by GOIRC.

@en

prefLabel

Adjuvant chemotherapy in compl ...... III trial conducted by GOIRC.

@ast

Adjuvant chemotherapy in compl ...... III trial conducted by GOIRC.

@en

P1433

Q33378937-CEA71DA7-6328-41A8-B00C-E221B7CA9833

P1476

Q33378937-F9BE1299-B49B-4B26-9F88-E6309EC32EFC

P2093

Q33378937-03946B61-C617-4687-B11E-F7F834E1AD5D

Q33378937-0565637E-7A36-4CF3-972C-5B39E3273565

Q33378937-07A51A20-2243-43B1-8652-C7DD83FE340A

Q33378937-07D2A64E-193D-4713-B220-A9A5AC18B290

Q33378937-09BE4C9D-E5E4-497C-A732-616321CD05A4

Q33378937-0BC72CC7-95A4-46A3-B0C4-22A492597016

Q33378937-0E1BB027-5E9A-4938-9392-2BBFF908C01E

Q33378937-0ECA11EF-08A5-4C8A-90E3-2BC4C1DB40E3

Q33378937-0F43D4CF-BE2C-4C81-B9E5-A1EB06B1FB3C

Q33378937-11B65BF6-1E49-45AF-83FF-F43467FCA53F

P2860

Q33378937-01B78347-4111-45F5-8019-F286572A1E99

Q33378937-055558EE-060D-4581-ACE7-C0FA63738178

Q33378937-1539DD26-0910-48F7-87AB-B8E23EC00BBA

Q33378937-2B9CBB23-9974-4CCC-863D-4C6E598A9A3F

Q33378937-384AA070-2D6D-4316-B92A-2711DAA747D3

Q33378937-7EE68441-8D46-493A-A153-DF6E9B07A961

Q33378937-874D1A3F-BFDF-4DF6-AD89-AF5894D90F2E

Q33378937-8C4771D7-3815-4C63-ABC6-407E2AA6B851

Q33378937-9431A30E-AB3E-4666-902A-1F4FBDFD846C

Q33378937-9DE101EA-694E-442D-9FAA-89880B6EE765

P304

Q33378937-9AAF826E-27DD-4CA8-89CF-C9CDB6B43849

P31

Q33378937-349DAD12-6294-40E8-8C01-7C17CE8FFB78

P356

Q33378937-78F49280-4BEB-442D-830C-82F56F2F754D

P407

Q33378937-ABD4F97E-E8F3-4DE8-88CF-A62F814241C8

P433

Q33378937-2AD3F95A-E50B-4896-B76B-051DE3A4D796

P478

Q33378937-B2222CDA-C5CB-4AE5-B684-923B46D6D94D

P50

Q33378937-24939375-E5EE-4CD2-A8B5-78669EBA804B

Q33378937-5CDC026F-9715-4A30-9F8E-938CCF576375

P577

Q33378937-72A012E3-3E93-4BD4-BDAA-D0663C4CE98A

P5875

Q33378937-2570BF76-1531-4748-A638-24FD952645D4

P698

Q33378937-B7166E3F-E156-4733-A7DF-40796BBB0644

P921

Q33378937-39CE3FF3-BD25-43E7-A5B5-957105CFEA85

Q33378937-5BD03B22-EE82-466C-89F4-3873C13E93E5

P356

P1433

Journal of the National Cancer Institute

P1476

Adjuvant chemotherapy in compl ...... III trial conducted by GOIRC.

@en

P2093

Adriana Romiti

http://www.w3.org/2001/XMLSchema#string

Alessandra Olivetti

http://www.w3.org/2001/XMLSchema#string

Alessandro Cabassi

http://www.w3.org/2001/XMLSchema#string

Alessandro Giunta

http://www.w3.org/2001/XMLSchema#string

Andrea Piga

http://www.w3.org/2001/XMLSchema#string

Andrea Pisani Leretti

http://www.w3.org/2001/XMLSchema#string

Angelo Dalla Mola

http://www.w3.org/2001/XMLSchema#string

Angelo Dinota

http://www.w3.org/2001/XMLSchema#string

Angelo Nicolosi

http://www.w3.org/2001/XMLSchema#string

Angelo Olgiati

http://www.w3.org/2001/XMLSchema#string

P2860

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis.

Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian Trials in Medical Oncology (ITMO) Group.

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials.

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

Roe versus reality--abortion and women's health.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Adjuvant therapy in gastric cancer.

P304

388-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJN054

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

100

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Cascinu

Roberto Labianca

P577

2008-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5517014

http://www.w3.org/2001/XMLSchema#string

P698

18334706

http://www.w3.org/2001/XMLSchema#string

P921

phase III clinical trial